DNAM1 and 2B4 Costimulatory Domains Enhance the Cytotoxicity of Anti-GPC3 Chimeric Antigen Receptor-Modified Natural Killer Cells Against Hepatocellular Cancer Cells in vitro
出版年份 2020 全文链接
标题
DNAM1 and 2B4 Costimulatory Domains Enhance the Cytotoxicity of Anti-GPC3 Chimeric Antigen Receptor-Modified Natural Killer Cells Against Hepatocellular Cancer Cells in vitro
作者
关键词
-
出版物
Cancer Management and Research
Volume Volume 12, Issue -, Pages 3247-3255
出版商
Informa UK Limited
发表日期
2020-05-08
DOI
10.2147/cmar.s253565
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of abnormally expressed genes and their roles in invasion and migration of hepatocellular carcinoma
- (2020) Jia-Ning Zhang et al. Aging-US
- 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
- (2019) Yingxi Xu et al. Journal of Hematology & Oncology
- Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
- (2019) Stefan Stoiber et al. Cells
- DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
- (2019) Beatriz Sanchez-Correa et al. Cancers
- Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
- (2019) Takahiro Nishida et al. Cancers
- Chimeric antigen receptor-engineered T-cell therapy for liver cancer
- (2018) Yang Chen et al. Hepatobiliary & Pancreatic Diseases International
- Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma
- (2018) Armin Ghobadi Current Research in Translational Medicine
- Off-the-Shelf CAR-NK Cells for Cancer Immunotherapy
- (2018) Elizabeth L. Siegler et al. Cell Stem Cell
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment
- (2018) Laura Agresta et al. Frontiers in Immunology
- Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimens
- (2017) Jinjing Xu et al. Expert Review of Anticancer Therapy
- Promises and limitations of nanoparticles in the era of cell therapy: Example with CD19-targeting chimeric antigen receptor (CAR)-modified T cells
- (2017) Hélène Jakobczyk et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma
- (2017) Qunfeng Wu et al. MOLECULAR THERAPY
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
- (2017) Jieming Zeng et al. Stem Cell Reports
- Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
- (2017) An Tang et al. Abdominal Radiology
- Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
- (2016) Ran Xu Zhu et al. Gut and Liver
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNAM-1: would the real natural killer cell please stand up!
- (2015) Nicholas D. Huntington et al. Oncotarget
- Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity
- (2015) Hai Wang et al. NEOPLASIA
- Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
- (2014) Masafumi Ikeda et al. CANCER SCIENCE
- Treatment of hepatocellular carcinoma: present and future
- (2013) Chiara Genco et al. Expert Review of Anticancer Therapy
- Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
- (2013) Jorge Filmus et al. FEBS Journal
- Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1
- (2011) Ruipeng Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Generation of high-titer viral preparations by concentration using successive rounds of ultracentrifugation
- (2011) Christine V Ichim et al. Journal of Translational Medicine
- Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
- (2010) Kiyotaka Nakano et al. ANTI-CANCER DRUGS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now